Saga Tankers ASA :Q3 2017 financial results
(Oslo, 29 November 2017) Saga Tankers ASA ("Saga", OSE: SAGA) reported a net asset value (NAV) of NOK 403 million at the end of the third quarter of 2017, corresponding to NOK 1.51 per outstanding share, excluding minority interests and with Vallhall valued at book value.
By the end of third quarter, Saga had a cash balance of NOK 63 million. All long term debt are related to the real estate in Vallhall (Saga's ownership is 55%).
During the quarter the net change in market value of SD Standard Drilling Plc, Vistin Pharma ASA and Pareto Bank ASA was negative NOK 6.85 million, classified as other comprehensive income.
Saga has increased its investment in SD Standard Drilling Plc through the quarter from 15.8% to 18.2%. No further changes have been made in the investment portfolio during the third quarter.
Key figures
| NOK 1000 | Jul-Sep 2017 | Jul-Sep 2016 | Jan-Sep 2017 | Jan-Sep 2016 |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |
| Operating revenues | 3 993 | 3 768 | 55 975 | 131 147 |
| Operating profit (-loss) before depreciation (EBITDA) (1) | 266 | -4 178 | 42 624 | 112 765 |
| Operating profit/(-loss) (EBIT) (2) | -393 | -4 908 | 40 648 | 110 574 |
| Net profit/(-loss) | -151 | -4 916 | 41 258 | 111 180 |
| Total comprehensive income | -6 997 | 21 281 | 11 616 | -107 248 |
| Value adjusted equity per share (NOK) (3) | 1,51 | 2,89 | 1,51 | 2,89 |
| Basic and diluted earnings per share NOK | -0,00 | -0,02 | 0,15 | 0,39 |
| (1) EBITDA can be calculated from the statement of income by deducting interest income, interest expenses and depreciation from the profit/(loss) before taxes. | ||||
| (2) EBIT can be calculated from the statement of income by deducting interest income and interest expenses from the profit/(loss) before taxes. | ||||
| (3) Value adjusted equity has been calculated through application of market value for assets and liabilities traded in quoted markets, and book value for other assets and liabilities. As traded assets and liabilities are carried at fair value in the balance sheet, the VAE per share equals total equity excluding non-controlling interests per outstanding share. | ||||
| TNOK | Share of total | |
| Fixed assets | 93 266 | 19 % |
| Available-for-sale financial assets | 323 181 | 67 % |
| Associates | 0 | 0 % |
| Current assets | 65 294 | 14 % |
| Total assets | 481 740 | 100 % |
| Available-for-sale financial assets | Fair value TNOK | No of shares | Ownership |
| Pareto Bank ASA | 182 397 | 5 052 547 | 8,60 % |
| SD Standard Drilling Plc | 90 109 | 64 826 667 | 18,17 % |
| Vistin Pharma ASA | 42 071 | 1 965 943 | 11,50 % |
| Other investments | 8 604 | ||
| Total | 323 181 |
Financial assets are adjusted to market value according to IFRS. Vallhall Arena is a subsidiary.
By end of third quarter the main investments in Saga Tankers ASA were:
Pareto Bank ASA ( 8.6% ownership)
Pareto Bank is a leading niche player within project financing. The bank has main focus on financing of real estate, securities and corporate, shipping and offshore. Pareto Bank is a compact organization with approximately 35 employees, short decision lines, and an efficient credit decision process. The main geographical real estate exposure is in Oslo and Akershus. Financing of securities is mainly related to listed stocks. Pareto Bank also finance small and medium size corporate, primarily related to a project or M&A. Further Pareto Bank finance some segments within the shipping and offshore industry.
For further information: www.paretobank.no
SD Standard Drilling Plc (18.2% ownership):
Main assets are currently investments within the PSV segment and cash holdings. The company currently owns 100% of five large-size PSV's and has ownership in 13 mid-size PSV's bringing the total fleet of party and/or fully owned vessels to 18.
For more information: www.standard-drilling.com
Vistin Pharma ASA (11.5% ownership):
Vistin Pharma is a Norwegian pharmaceutical company producing Active
Pharmaceutical Ingredients (APIs) and solid dosage forms for the global
pharmaceutical industry. The company has key positions in the Metformin and
Opioids markets, and a strong foundation for creating a highly efficient CMO
business (contract manufacturing of tablets). Solid growth potentials exist in
all the business segments. The spin-off from Weifa facilitates new growth
opportunities due to a narrower business scope, increased visibility and being
able to pursue own strategic agendas without the risk of compromises across business units.
The company has agreed to sell the opioids and tablet manufacturing business to TPI Enterprises Limited. The transaction is expected to be closed in the fourth quarter of 2017.
Upon completion of the transaction, Vistin Pharma ASA will be a pure play metformin producer, with a strong position in the global market and with significant growth amibitions.
For further information: www.vistin.com
Vallhall (55% ownership):
Vallhall Arena is Oslo's largest indoor arena, centrally located at Helsfyr in Oslo with good public transportation connections. Several hotels are also located close to the arena. The arena was built in 2001. The cost was approximately NOK 130 million whereof NOK 80 million was funded by debt and NOK 55 million was funded by equity from owners. The arena has about 9 000 square meter expanse. The arena is well-known for its high quality indoor soccer hall and is used by school children, as well as professionals. The arena is also leased out for events such as exhibitors, seminars, concerts and other events requiring facilities that Vallhall Arena can offer.
For more information: www.vallhall.no
For further information, please contact:
CEO Espen Lundaas
+47 92 43 14 17